IDENTIFICATION OF PROGNOSTIC SUBGROUPS BY FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES

被引：0
|
作者：
van de Loosdrecht, Arjan [1 ]
Canan, Alhan [1 ]
Ossenkoppele, Gert [1 ]
Westers, Theresia [1 ]
机构：
[1] Vrije Univ Amsterdam, Med Ctr, Dept Hematol, Amsterdam, Netherlands
来源：
CYTOMETRY PART B-CLINICAL CYTOMETRY | 2009年 / 76B卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：416 / 416
页数：1
相关论文
共 50 条
  • [21] Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile
    Guarnera, Luca
    Fabiani, Emiliano
    Attrotto, Cristina
    Hajrullaj, Hajro
    Cristiano, Antonio
    Latagliata, Roberto
    Fenu, Susanna
    Buccisano, Francesco
    Irno-Consalvo, Maria
    Conti, Consuelo
    Voso, Maria Teresa
    Maurillo, Luca
    [J]. ANNALS OF HEMATOLOGY, 2023, 102 (11) : 3015 - 3023
  • [22] Comparison of five diagnostic flow cytometry scores in patients with myelodysplastic syndromes: Diagnostic power and prognostic impact
    Oelschlaegel, Uta
    Oelschlaeger, Lorenz
    von Bonin, Malte
    Kramer, Michael
    Sockel, Katja
    Mohr, Brigitte
    Wagenfuehr, Lisa
    Kroschinsky, Frank
    Bornhaeuser, Martin
    Platzbecker, Uwe
    [J]. CYTOMETRY PART B-CLINICAL CYTOMETRY, 2023, 104 (02) : 141 - 150
  • [23] The prognostic impact of karyotypic subgroups in myelodysplastic syndromes is strongly modified by sex
    Mauritzson, N
    Johansson, B
    Rylander, L
    Albin, M
    Strömberg, U
    Billström, R
    Ahlgren, T
    Mikoczy, Z
    Mitelman, F
    Hagmar, L
    Nilsson, PG
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (02) : 347 - 356
  • [24] Prognostic relevance of cytogenetic subgroups in 357 patients with myelodysplastic syndromes.
    Haase, D
    Schanz, J
    Wulich, J
    Schoch, C
    Freund, M
    Haferlach, T
    Wormann, B
    Staib, P
    Lentini, G
    Bartels, H
    Geissler, RG
    Germing, U
    Dorges, U
    Fonatsch, C
    Hiddemann, W
    [J]. BLOOD, 1997, 90 (10) : 2232 - 2232
  • [25] Machine Learning Approach Identifies Independent Prognostic Value of Flow Cytometry (FCM) in Myelodysplastic Syndromes (MDS)
    Oelschlaegel, Uta
    Blighe, Kevin
    Winter, Susann
    Sockel, Katja
    Bornhaeuser, Martin
    Kordasti, Shahram
    Platzbecker, Uwe
    [J]. BLOOD, 2019, 134
  • [26] Flow cytometry in myelodysplastic syndromes: Ready for translation into clinical practice
    van de Loosdrecht, Arjan A.
    Westers, Theresia M.
    [J]. LEUKEMIA RESEARCH, 2011, 35 (07) : 850 - 852
  • [27] Application of Flow Cytometry for Myelodysplastic Syndromes: Pitfalls and Technical Considerations
    Alhan, Canan
    Westers, Theresia M.
    Cremers, Eline M. P.
    Cali, Claudia
    Ossenkoppele, Gert J.
    van de Loosdrecht, Arjan A.
    [J]. CYTOMETRY PART B-CLINICAL CYTOMETRY, 2016, 90 (04) : 358 - 367
  • [28] FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES. DEFINITIONS AND CLINICAL APPLICATIONS
    van de Loosdrecht, Arjan A.
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2012, 34 : 37 - 38
  • [29] Distinct neutrophil subpopulations phenotype by flow cytometry in myelodysplastic syndromes
    Vikentiou, Myrofora
    Psarra, Katerina
    Kapsimali, Violetta
    Liapis, Konstantinos
    Michael, Michalis
    Tsionos, Konstantinos
    Lianidou, Evi
    Papasteriades, Chryssa
    [J]. LEUKEMIA & LYMPHOMA, 2009, 50 (03) : 401 - 409
  • [30] Diagnostic flow cytometry for low-grade myelodysplastic syndromes
    Ogata, Kiyoyuki
    [J]. HEMATOLOGICAL ONCOLOGY, 2008, 26 (04) : 193 - 198
12345